Licorice
Licorice is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 1912herb co heart well herb | unapproved drug other | 2024-11-10 |
| allspice almond apricot artichoke asparagus avocado banana barley grain bay leaf beet black olive black pepper blackberry blackeye pea blueberry br... | Biologic Licensing Application | 2009-12-09 |
| baekcho-ds | unapproved drug other | 2019-04-02 |
| baenosin | unapproved drug other | 2023-12-16 |
| licorice root whitening cream | C200263 | 2024-11-24 |
| ludens honey lemon throat drops ludens honey licorice throat drops ludens menthol throat drops | OTC monograph not final | 2017-12-20 |
| ludens honey lemon throat drops ludens honey licorice throat drops ludens original menthol throat drops | C200263 | 2020-06-30 |
| melao whitening cream | C200263 | 2024-11-19 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
105 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | 1 | 1 | — | 2 |
| Hypokalemia | D007008 | — | E87.6 | — | — | — | 1 | — | 1 |
| Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | — | — | — | 1 | — | 1 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | 1 | — | 1 |
| Premature birth | D047928 | EFO_0003917 | O60 | — | — | — | 1 | — | 1 |
| Ventricular premature complexes | D018879 | — | I49.3 | — | — | — | 1 | — | 1 |
| Macular edema | D008269 | — | — | — | — | — | 1 | — | 1 |
| Edema | D004487 | — | R60.9 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Syndrome | D013577 | — | — | 2 | 3 | 2 | — | 3 | 8 |
| Covid-19 | D000086382 | — | U07.1 | 1 | 3 | 1 | — | 3 | 6 |
| Dental caries | D003731 | EFO_0003819 | K02 | — | 1 | 1 | — | 3 | 4 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | 2 | 1 | — | 1 | 4 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | 1 | — | 1 | 2 |
| Hyperaldosteronism | D006929 | — | E26 | — | 1 | 1 | — | 1 | 2 |
| Apparent mineralocorticoid excess syndrome | D043204 | EFO_1000817 | — | — | 1 | 1 | — | 1 | 2 |
| Colorectal neoplasms | D015179 | — | — | — | 1 | 1 | — | — | 2 |
| Allergic rhinitis | D065631 | — | J30.9 | 1 | — | 1 | — | — | 2 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 1 | — | 1 | — | — | 2 |
Show 6 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 2 | 2 | — | — | 1 | 4 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | 2 | — | — | 2 | 4 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 1 | — | — | 2 | 3 |
| Sleep initiation and maintenance disorders | D007319 | — | F51.01 | 1 | 1 | — | — | 2 | 3 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 1 | 1 | — | — | 2 | 3 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | — | — | 2 | 3 |
| Gingivitis | D005891 | — | K05.10 | — | 1 | — | — | 1 | 2 |
| Communicable diseases | D003141 | — | — | 1 | 2 | — | — | — | 2 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 1 | — | — | 1 | 2 |
| Dermatitis | D003872 | — | L30.9 | 1 | 1 | — | — | 1 | 2 |
Show 37 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chinese traditional medicine | D008516 | — | — | 2 | — | — | — | 2 | 4 |
| Harm reduction | D040261 | — | — | 3 | — | — | — | — | 3 |
| Smoking cessation | D016540 | EFO_0004319 | — | 3 | — | — | — | — | 3 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | — | — | — | 1 | 2 |
| Helicobacter infections | D016481 | EFO_1000961 | — | 1 | — | — | — | 1 | 2 |
| Food-drug interactions | D018565 | — | — | 1 | — | — | — | — | 1 |
| Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | — | 1 |
| Squamous cell carcinoma | D002294 | — | — | 1 | — | — | — | — | 1 |
| Squamous cell neoplasms | D018307 | — | — | 1 | — | — | — | — | 1 |
Show 9 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | — | — | — | — | 4 | 4 |
| Essential hypertension | D000075222 | — | I10 | — | — | — | — | 3 | 3 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 3 | 3 |
| Gastrointestinal diseases | D005767 | — | — | — | — | — | — | 2 | 2 |
| Asthma | D001249 | EFO_0000270 | J45 | — | — | — | — | 2 | 2 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | — | 2 | 2 |
| Gastrointestinal microbiome | D000069196 | — | — | — | — | — | — | 2 | 2 |
| Overweight | D050177 | — | E66.3 | — | — | — | — | 1 | 1 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | — | — | — | 1 | 1 |
| Iga vasculitis | D011695 | EFO_1000965 | D69.0 | — | — | — | — | 1 | 1 |
Show 41 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Licorice |
| INN | _ |
| Description | Liquorice (British English) or licorice (American English; IPA: /ˈlɪkərɪʃ, -ɪs/ LIK-ər-ish, -iss) is the common name of Glycyrrhiza glabra, a flowering plant of the bean family Fabaceae, from the root of which a sweet, aromatic flavouring is extracted.
|
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | 1HDC |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2109060 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 61ZBX54883 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Allspice almond apricot artichoke asparagus avocado banana barley grain bay leaf beet black olive black pepper blackberry blackeye pea blueberry br...
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
95 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use